Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual ...

Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...

‘After all the horrible things we’ve been through,’ he said to me, ‘if I die of cancer, it will make a bad story’: Siri Hustvedt on losing Paul Auster

First there was the double tragedy that tore the family apart – then came a deadly diagnosis. The writer reflects on life after the death of her novelist husband ...

Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy

Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of the overlooked growth stocks to buy now. On April 1, Zai Lab and Amgen ...
GEN

StockWatch: Revolution’s Phase III Pancreatic Cancer Data Dazzles Investors, Analysts

Pancreatic cancer is one of the most difficult cancers to treat, with an overall five-year survival rate of 13%, according to ...

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712

MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with preclinical data indicating favorable therapeutic window ...